Title: THE TREATMENT OF OESOPHAGEAL VARICES AND PORTAL HYPERTENSION
Abstract: Journal of Clinical Pharmacy and TherapeuticsVolume 10, Issue 1 p. 1-14 Free Access THE TREATMENT OF OESOPHAGEAL VARICES AND PORTAL HYPERTENSION D. Clements, D. Clements Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2THSearch for more papers by this authorE. Elias, E. Elias Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2THSearch for more papers by this author D. Clements, D. Clements Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2THSearch for more papers by this authorE. Elias, E. Elias Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2THSearch for more papers by this author First published: March 1985 https://doi.org/10.1111/j.1365-2710.1985.tb00712.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat REFERENCES 1 Richardson, P.D.I. & Withrington, P.G. (1981) Liver blood flow I. Intrinsic and nervous control of liver blood flow. Gastroenterology, 81, 159– 173. 2 Lautt, W.W. (1982) Relationship between hepatic arterial blood flow and overall metabolism: the hepatic arterial buffer response. Federation Proceedings, 42, 1662– 1666. 3 Child, C.G. & Turcotte, J.G. (1964) Surgery and portal hypertension. The liver and portal hypertension. (ed. C. G. Child), p. 50. W.B. Saunders, Philadelphia . 4 Pugh, R.N.H., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C. & Williams, R. (1973) Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery, 60, 646– 649. 5 Conn, H.O. (1981) A peek at the Child-Turcotte classification. Hepatology, 1, 673– 676. 6 Groszman, R.J., Glickman, M., Blei, A.T., Storer, E. & Conn, H.O. (1979) Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology, 76, 253– 258. 7 Lebrec, D., Bercoff, E., Menu, Y., Bataille, C. & Valla, D. (1983) Comparison of the effect of propranolol on wedged hepatic venous pressure and portal pressure in patients with cirrhosis. Gastroenterology, 84 Abst., 1380. 8 Mosimann, R. (1982) Nonaggressive assessment of portal hypertension using endoscopic measure of variceal pressure. Preliminary report. American Journal of Surgery, 143, 212– 214. 9 McCormack, T., Martin, T., Smallwood, R.H., Robinson, P., Walton, L. & Johnson, A.G. (1983) Doppler ultrasound probe for assessment of blood flow in oesophageal varices. Lancet, i, 677– 678. 10 Bosch, J. & Groszman, R.J. (1984) Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology, 4, 424– 429. 11 Ponce, J., Frouf, F., de la Morena, E., Mir, J., Rayon, M., Pina, R. & Berenguer, J. (1981) Morphometric study of the esophageal mucosa in cirrhotic patients with variceal bleeding. Hepatology, 1, 641– 646. 12 Eckhardt, V.F. & Grace, N.D. (1979) Gastroesophageal reflux and bleeding esophageal varices. Gastroenterology, 76, 39– 42. 13 Lebrec, D., De Fleury, P., Rueff, B., Nahum, H. & Benhamou, J-P. (1980) Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology, 79, 1139– 1144. 14 Baker, L.A., Smith, C. & Lieberman, G. (1959) The natural history of esophageal varices. A study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding. American Journal of Medicine, 26, 228– 237. 15 Kehne, J.H., Hughes, F.A. & Compeertz, M.L. (1956) The use of pituitrin in the control of esophageal varix bleeding. Surgery, 39, 917. 16 Merigan, T.C. Jr., Plotkin, G.R. & Davidson, C.S. (1961) Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. A controlled evaluation. New England Journal of Medicine, 266, 134– 135. 17 Kerr, J.C., Hobson, R.W., Seelig, R.F. & Swan, K.G. (1978) Vasopressin: route of administration and effects on canine hepatic and superior mesenteric arterial flows. Annals of Surgery, 187, 138– 142. 18 Fingeroth, R.J., Storer, E.G., Ramsby, G.R. & Conn, H.O. (1973) Effect of intraarterial infusions of vasopressin on hepatic artery flow. Surgical Forum, 24, 399– 402. 19 Goldfarb, J.P., Heller, T., Bazari, H., Carnevale, N. & Wapwick, S. (1984) Response of vasopressin: an early prognostic indicator in variceal haemorrhage. Gastroenterology, 86, 1092 abstract. 20 Conn, H.O., Ramsby, G.R., Storer, E.H., Mutchnik, M.G., Joshi, P.H., Phillips, M.M., Cohen, G.A., Fields, G.N. & Petroski, D. (1975) Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: A prospective, controlled clinical trial. Gastroenterology, 68, 211– 221. 21 Mallory, A., Schaefer, J.W., Cohen, J.R., Holt, S.A. & Norton, L.W. (1980) Selective intraarterial vasopressin in the treatment of upper gastrointestinal haemorrhage: a controlled trial. Archives of Surgery, 115, 30– 32. 22 Chojkier, M., Groszmann, R.J., Atterbury, C.E., Bar-Meir, S., Blei, A.T., Frankel, J., Glickman, M.G., Kniaz, J.L., Schade, R., Taggart, G.J. & Conn, H.O. (1979) A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology, 77, 540– 546. 23 Sagar, S., Harrison, I.D., Brearley, R. & Shields, R. (1979) Emergency treatment of variceal haemorrhage. British Journal of Surgery, 66, 824– 826. 24 Freeman, J.G., Cobden, I., Lishman, A.H. & Record, C.O. (1982) Controlled trial of terlipressin (‘glypressin’) versus vasopressin in the early treatment of oesophageal varices. Lancet, ii, 66– 68. 25 Vosmik, J., Jedlicka, K., Mulder, J.L. & Cort, J.H. (1977) Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices. Gastroenterology, 72, 605– 609. 26 Groszman, R.J., Kravitz, D., Bosch, J., Glickman, M., Bruix, J., Bredfeldt, J., Conn, H.O., Rodes, J. & Storea, E.H. (1982) Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology, 6, 757– 762. 27 Sirinek, K.R. & Thomford, N.R. (1975) Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients. American Journal of Surgery, 129, 130– 136. 28 Mols, P., Hallemans, R., Van Kuyk, M., Melot, C., Lejeune, P., Ham, H., Vertongen, F. & Naeije, R. (1984) Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension. Annals of Surgery, 199, 176– 181. 29 Wahren, J. & Felig, P. (1976) Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet, ii, 1213– 1216. 30 Sheppard, M., Shapiro, B., Pimstone, B., Kronheim, S., Berelowitz, M. & Gregory, M. (1979) Metabolic clearance and plasma half-disappearance of exogenous somatostatin in man. Journal of clinical endocrinology and metabolism, 48, 50– 53. 31 Bosch, J., Kravetz, D. & Rodes, J. (1981) Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology, 80, 518– 525. 32 Sonnenberg, G.E., Keller, U., Perruchoud, A., Burckhardt, D. & Gyr, K. (1981) Effect of somatostatin on splanchnic hemodynamic in patients with cirrhosis of the liver and in normal subjects. Gastroenterology, 80, 526– 532. 33 Thulin, L., Tyden, G., Samnegard, H., Muhrbeck, O. & Efendic, S. (1979) Treatment of bleeding esophageal varices with somatostatin. Acta Chirurgica Scandinavica, 145, 395– 398. 34 Raptis, S. & Zoupas, C. (1979) Somatostatin not helpful in bleeding esophageal varices. New England Medical Journal, 300, 736– 737. 35 Kravetz, D., Bosch, J., Teres, J., Bruix, J., Rimola, A. & Rodes, J. (1984) Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal haemorrhage. Hepatology, 4, 442– 446. 36 Lebrec, D., Bernau, J., Rueff, B. & Benhamou, J-P. (1982) Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis. New England Journal of Medicine, 307, 560. 37 Rowntree, L.G., Zimmerman, E.F., Todd, M.H. & Ajac, J. (1947) Intraesophageal venous tamponade. Its use in a case of variceal hemorrhage from the esophagus. Journal of the American Medical Association, 135, 630– 631. 38 Sengstaken, R.W. & Blakemore, A.H. (1950) Balloon tamponade for the control of hemorrhage from esophageal varices. Annals of Surgery, 131, 781– 789. 39 Clanet, J., Tournut, R., Fourtanier, G., Joncquiert, F. & Pascal, J.P. (1978) Traitement par la pitressine des hemorragies par rupture de varices oesophagiennes chez le cirrhotique. Acta Gastroenterologica Belgica, 41, 539– 543. 40 Crafoord, C. & Frenckner, P. (1939) New surgical treatment of varicose veins of the oesophagus. Acta Oto-laryngologica (Stockholm), 27, 422– 429. 41 Westaby, D., Macdougall, B.R.D., Melia, W., Theodossi, A. & Williams, R. (1983). A prospective randomized study of two sclerotherapy techniques for esophageal varices. Hepatology, 3, 681– 684. 42 Barsoum, M.S., Bolous, F.I., El-Roody, A.A., Rizk-Allah, M.A. & Ibrahim, A.S. (1982) Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. British Journal of Surgery, 69, 76– 78. 43 Paquet, K.J. & Oberhammer, E. (1978) Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy, 10, 7– 12. 44 Johnston, G.W. & Rodgers, H.W. (1973) A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. British Journal of Surgery, 60, 797– 800. 45 Terblanche, J., Northover, J.M.A., Bornman, P., Kahn, D., Barbezat, G.O., Sellars, S.L. & Saunders, S.J. (1979) A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices. Surgery, 85, 239– 245. 46 Terblanche, J., Northover, J.M.A., Bornman, P., Kahn, D., Silber, W., Barbezat, G.O., Sellars, S., Campbell, J.A.H. & Saunders, S.J. (1979) A prospective controlled trial of sclerotherapy in the long-term management of patients with esophageal variceal bleeding. Surgery, Gynecology & Obstetrics, 148, 323– 333. 47 Macdougall, B.R.D., Westaby, D., Theodossi, A., Dawson, J.L. & Williams, R. (1982) Increased long term survival in variceal haemorrhage using injection sclerotherapy: results of a controlled trial. Lancet, i, 124– 127. 48 Paquet, K.J. (1982) Prophylactic endoscopic sclerosing treatment of esophageal wall in varices—a prospective controlled randomized trial. Endoscopy, 14, 4– 5. 49 Galambos, J.T. (1983) Endoscopic sclerotherapy. Annals of Internal Medicine, 98, 1009– 1011. 50 Conn, H.O. (1983) Endoscopic sclerotherapy: an analysis of variants. Hepatology, 3, 769– 771. 51 Marzuk, P.M. & Schwartz, J.S. (1984) Endoscopic sclerotherapy of esophageal varices. Annals of Internal Medicine, 100, 608– 610. 52 Lunderquist, A. & Vang, J. (1974) Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. New England Journal of Medicine, 291, 646– 649. 53 Burroughs, A.K., Bass, N.M., Osborne, D., Dick, R., Hobbs, K.F. & Sherlock, S. (1983) Randomised, controlled study of transhepatic obliteration of varices and oesophageal stapling transection in uncontrolled variceal haemorrhage. Liver, 3, 122– 128. 54 Smith-Laing, G., Scott, J., Long, R.G., Dick, R. & Sherlock, S. (1979) Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology, 80, 1031– 1036. 55 Orloff, M.J., Bell, R.H., Hyde, P.V. & Skivolocki, W.P. (1980) Long term results of emergency portacaval shunts for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Annals of Surgery, 192, 325– 340. 56 Warren, W.D., Milliku, W.J., Henderson, J.M., Wright, L., Kutner, M., Smith, R., Fulenwider, T., Salam, A.A. & Galambos, J.T. (1982) Ten years portal hypertension surgery at Emory: Results and new perspectives. Annals of Surgery, 195, 530– 542. 57 Feeley, J., Wilkinson, G.R. & Wood, A.J.J. (1981) Reduction of liver blood flow and propranolol metabolism by cimetidine. New England Journal of Medicine, 304, 692– 695. 58 Schneider, R.E. & Bishop, H. (1981) H2 receptor antagonists for portal hypertension. Lancet, ii, 152. 59 Macdougall, B.R.D. & Williams, R. (1983) A controlled clinical trial of cimetidine in the recurrence of variceal hemorrhage: implications about the pathogenesis of hemorrhage. Hepatology, 3, 69– 73. 60 Burroughs, A.K., Walt, R., Dunk, A., Jenkins, W., Sherlock, S., Mackie, S. & Dick, R. (1982) Effect of cimetidine on portal hypertension in ciirhoticpatients. British Medical Journal, 284, 1159– 1160. 61 Grace, N.D. (1983) The misuse of cimetidine in patients with cirrhosis. Hepatology, 3, 124– 125. 62 Dunk, A.A., Jenkins, W.J., Burroughs, A.K., Walt, R.P., Osuafor, T.O.K., Sherlock, S., Mackie, S. & Dick, R. (1983) The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease. British Journal of Clinical Pharmacology, 16, 117– 120. 63 Grainger, S.L., Ainley, C.C. & Thompson, R.P.H. (1984) Do H2-receptor antagonists affect liver blood flow and why Gut, 25, A571. 64 Macdougall, B.R.D., Bailey, J.R. & Williams, R. (1977) H2-receptor antagonists and antacids in the prevention of acute gastrointestinal hemorrhage in fulminant hepatic failure. Lancet, ii, 617– 619. 65 Lebrec, D., Nouel, O., Corbie, M. & Benhamou, J-P. (1980) Propranolol—a medical treatment for portal hypertension Lancet, ii, 180– 182. 66 Lebrec, D., Poynard, T., Hillon, P. & Benhamou, J-P. (1981) Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study. New England Journal of Medicine, 305, 1371– 1374. 67 Lebrec, D., Poynard, T., Bernau, J., Bercoff, E., Nouel, O., Capron, J-P., Poupon, R., Bouvry, M., Rueff, B. & Benhamou, J-P. (1984) A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology, 4, 355– 358. 68 Westaby, D., Bihari, D.J., Gimson, A.E.S., Crossley, I.R. & Williams, R. (1984) Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut, 25, 121– 124. 69 Lebrec, D., Hillon, P., Munoz, C., Goldfarb, G., Nouel, O. & Benhamou, J-P. (1982) The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology, 2, 523– 527. 70 Bataille, C., Bercoff, E., Pariente, E.A., Valla, D. & Lebrec, D. (1984) Effects of propranolol on renal blood flow and renal function in patients with cirrhosis. Gastroenterology, 86, 129– 133. 71 Wilkinson, S.P., Wheeler, P.G., Bernardi, M. & Smith, I.K. (1979) Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of beta-adrenergic blockade. Postgraduate Medical Journal, 55, 862– 867. 72 Scholar, J., Iaian, A., Serban, I., Theodor, E. & Eliahou, H.E. (1979) The effect of propranolol on renal sodium handling in patients with cirrhosis. Biomedicine, 31, 128– 131. 73 Burroughs, A.K., Jenkins, W.J., Sherlock, S., Dunk, A., Walt, R.P., Osuafor, T.O.K., Mackie, S. & Dick, R. (1983) Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. New England Journal of Medicine, 309, 1539– 1542. 75 Garcia-Tsao, G., Groszman, R.J., Grace, N.D., Conn, H.O., Bermann, M., Patrick, H. & Alberts, G. (1984) Propranolol and portal hypertension. Gastroenterology, 86, 1320 abstract. 76 Colman, J., Mignot, P. & Dudley, F. (1984) Effect of acute and chronic oral propranolol on portal pressure. Gastroenterology, 86, 1315 abstract. 77 Rector, W.G. (1982) Propranolol for portal hypertension. Hepatology, 2, 678 abstract. 78 Conn, H.O. (1982) Propranolol in the treatment of portal hypertension: a caution. Hepatology, 2, 641– 644. 79 Mills, P.R., Rae, A.P., Farah, D.A., Russell, R.I., Lorimer, A.R. & Carter, D.C. (1984) Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension. Gut, 25, 73– 78. 80 Freeman, J.G., Barton, J.R. & Record, C.O. (1983) Effects of vasodilators on portal pressure in patients with portal hypertension. Gut, 24, A971. 81 Dawson, J., West, R., Gertsch, P., Mosiman, F. & Elias, E. (1983) Endoscopic variceal pressure measurements: response to isosorbide dinitrate. Gut, 24, A971. 82 Hallemans, R., Naeije, R., Mols, P., Melot, C. & Reding, P. (1983) Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin. Critical Care Medicine, 11, 536– 540. 83 Hillon, P., Lebrec, D., Munoz, C., Jungers, M., Goldfarb, G. & Benhamou, J-P. (1982) Comparison of the effects of a cardioselective and nonselective B-blocker on portal hypertension in patients with cirrhosis. Hepatology, 2, 528– 531. Citing Literature Volume10, Issue1March 1985Pages 1-14 ReferencesRelatedInformation